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INTRODUCTION
Anemia is one of the most common disorders principally 
characterized by a decline in the concentration of circulating 
erythrocytes or hemoglobin (Hgb) in the blood and a 
concomitant impairment of oxygen transportation that does 
not meet the body’s physiological need [1,2]. The cut-off value 
to define anemia varies with age, gender, altitude, smoking 
behavior, and stages of pregnancy [3].
Anemia is a global public health problem affecting both 
developing and developed countries with major consequences for 
human health as well as social and economic development [2]. 
It occurs at all stages of the life cycle but is more prominent 
in pregnant women, young children and other women of 
reproductive age [1,4-6]. Globally, anemia affects 1.62 billion 
people (24.8%), among which 56 million (41.8%) are pregnant 
women. It is a major public health problem particularly among 
poorer segments of the population in developing countries where 
95% of the world anemic pregnant women are residing [1,7]. The 
greatest burden of anemia in pregnant women is found in Asia 
and Africa content [2]. Of the total anemic pregnant women, 
about 57.1% have been residing in African countries.
In Ethiopia, it has also been estimated that 62.7% of pregnant 
women were suffering from anemic; and it is a severe public 
health problem [1,8]. It is the most frequent morbidity among 
pregnant women with a wide range of variation in magnitude at 
different geographical location. Moreover, evidences reveal that 
there is an urban-rural difference in the prevalence of maternal 
anemia [9-15]. It is still a public health problem because the 
nutritional status of women in Ethiopia is low while their 
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ABSTRACT
Background: Anemia during pregnancy is a major public health problem in developing and developed 
countries. It has been implicated with an increased risk of maternal and fatal morbidity and mortality. Hence, 
the main objective of this study was to assess the magnitude of maternal anemia during pregnancy at last 
antenatal care (ANC) visit at Bahirdar Felege-Hiwot referral hospital ANC clinic. Methods: An institutional-
based retrospective study was conducted in Bahirdar Felege-Hiwot Referral hospital from September 2012 
to August 2013. Data were collected from clinical recording charts using data extraction sheet. Both bivariate 
and multivariate analyses were done to see the association of independent variables with the outcome 
variable. Results: The mean gestational age was 31 weeks (range: 8-43). Of total 1120 pregnant women, 
508 (45.4%) of them were anemic. The mean Hemoglobin level of pregnant women was 10.98g/dL (±1.68 
standard deviation). Majority (50.4%) of these anemic women were mildly anemic. The remaining 46.5% 
and 3.1% were moderately and severely anemic. Immunodeficiency virus (HIV) infection was significantly 
associated with maternal anemia (adjusted odds ratio [95% confidence interval] = 4.78 [3.14, 7.29]). 
Concussion: The prevalence of anemia was high, and it is a severe public health problem. Mild type anemia 
was dominant. HIV infection was associated with maternal anemia. Hence, efforts should be made for early 
diagnosis and management of anemia and HIV.
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daily workload is often enormous to ensure survival of their 
children [16]. To reduce the risk of nutritional anemia during 
pregnancy, some strategic programs were formulated and are 
being implemented [17].
Anemia during pregnancy is harmful and associated with poor 
pregnancy outcomes. However, the extent to which maternal 
anemia affects maternal and neonatal health is still uncertain. 
There are several studies suggesting the possible associations of 
maternal anemia with maternal and child or fetus complications. 
It increases the risk of maternal and neonatal mortality and 
morbidity, preterm delivery, low birth weight, intrauterine fetal 
death, cognitive impairment, and lowered immune status of 
women [18-21]. It also implicates with the development of 
anemia in children born from anemic women which impairs 
child growth [22-24].
In developing countries like Ethiopia, the etiology of anemia is 
multifactorial and complex. It includes nutritional deficiencies, 
malabsorption, increased destruction of red cells, diminished 
erythropoiesis, loss of blood, and infectious agents [25,26]. Even 
though the relative contribution of each factor varies greatly by 
geographical location, season and dietary practice, nutritional 
deficiency is by far the most common cause of anemia in sub-
Saharan Africa [4]. During pregnancy, women are particularly 
susceptible to iron deficiency anemia (IDA) because of increased 
demands of iron for fetal development [27]. Thus, IDA is the 
most common contributing factor to total disability adjusted 
life years lost in the developing world [28].
Anemia prevalence data remain an important indicator of public 
health because it is being related to morbidity and mortality 
of vulnerable segment of the population such as pregnant 
women and preschool children [28]. Besides, at a global level, 
anemia prevalence is a useful indicator to monitor the impact 
of widespread or highly effective interventions and to track 
the progress made toward the goal of reducing anemia during 
pregnancy and maternal mortality [26,29]. Few epidemiological 
studies on the prevalence of anemia in pregnant women were 
done in a different part of Ethiopia and reported varying 
magnitude of the problem [9-15,30]. Because of the variability 
of factors associated with maternal anemia in different localities, 
studies have to be conducted in a different part of Ethiopia 
to understand the comprehensive epidemiology of anemia in 
Ethiopia. Therefore, the aim of this study was to determine 
the magnitude of maternal anemia among pregnant women 
who attended antenatal care (ANC) at Bahirdar Felege-hiwot 
Referral hospital in Northwest Ethiopia.
METHODS
This was a retrospective study conducted on pregnant women 
who registered at Bahirdar Felege-Hiwot Referral hospital ANC 
clinic, Northwest Ethiopia between September 1, 2012 and 
August 31, 2013. The hospital is found in Bahirdar city which 
is located approximately 565 km far from Addis Ababa to the 
North Western part of Ethiopia. The city is also found at an 
evaluation of about 1800 m above sea level; and it has an average 
temperature of 25° centigrade. Felege-Hiwot referral hospital 
is a tertiary health institution offering both primary health 
services and serving as a major referral center for the people of 
West Gojam district and the surrounding districts of Amhara 
regional state. It provides services for approximately 5-7 million 
people annually in Northwest Ethiopia.
All pregnant women who attended ANC between September 1, 
2012 and August 31, 2013 were included in the study. The 
case records of women registered for ANC were taken from 
ANC clinic, and the data were retrieved from medical record 
department of the hospital using data extraction sheet. The 
data obtained were age, residence, Hgb level, gestational 
age, gravidity, nutritional supplementation at their current 
pregnancy and human Immunodeficiency virus (HIV) sero-
status. The data were collected in March 2014.
To define anemia and classify the degree of severity, Hgb cut-off 
value after the measured Hgb was adjusted to sea level is used 
on the basis of gestational age using WHO criteria [30]. The 
Hgb <11.0g/dL at first and third trimesters and Hgb <10.5 g/dL 
at second trimester were used to define anemia. The Hgb value 
of 10g/dL ≤ Hgb <11g/dL) at first and third trimesters and 
10 g/dL ≤Hgb< 10.5 g/dL at second trimester were classified as 
mild anemia. Besides, Hgb value of 7 g/dL ≤Hgb<10 g/dL and 
Hgb <7 g/dL were categorized as moderate and severe anemic, 
respectively, regardless of gestational age [1,30].
The data were checked, sorted, and coded. Then data were 
entered to EPI info version 3.5.3 and transferred to Statistical 
Package for the Social Sciences (IBM, LA, US) version 20 for 
analysis. Description of mean, frequencies, and proportions of 
the given data for each variable were calculated and summarized 
in the form of tables and figure. Bivariate analysis was done 
to see the association of each independent variable with the 
outcome variable. Those variables having P < 0.2 were entered 
into the multivariate logistic regression model to identify the 
effect of each independent variable with the outcome variables. 
Variables having P < 0.05 in multivariate logistic regression 
analysis were considered statistically significant, and adjusted 
odds ratio with 95% confidence interval (CI) was calculated to 
determine the association.
The study was approved by institutional review board of the 
University of Gondar. Official supportive letter was also obtained 
from the diagnostic director and communicated with ANC clinic 
and medical record department of the Felege-Hiwot Referral 
hospital before commencement of data collection. All data 
obtained were kept confidential.
RESULT
Socio-demographic Characteristics
A total of 1120 pregnant women were included in the study. 
About 87.5% (980/1120) of the study participants were living 
in the urban area. The mean age of the study participants 
was 26.13 year (± 4.55 year standard deviation [SD]). The 
minimum and maximum age of the study participants were 17 
and 45 years, respectively [Table 1].
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Obstetrics and Medical Condition of Study Participants
Of the total study participants, 826 (73.80%) and 283 (25.3%) 
pregnant women had last ANC visit record at their third and 
second trimester, respectively. The mean gestational age at last 
ANC visit was 31 week (range: 8-43). Regarding the medical 
condition, 135 (12.1%) of them were HIV sero-reactive. About 
28 (2.5%) were hypertensive; of whom 7 (60.7%) were diastolic 
only, 8 (25.6%) were systolic only, and 3 (10.7) were both 
diastolic and systolic hypertensive. Almost all, 1118 (99.8%) 
study participants had taken nutritional supplements in their 
current pregnancy. The majority, 366 (32.7%) of the pregnant 
women attended ANC service at Felege-Hiwot Referral hospital 
once in their current pregnancy [Table 2].
PREVALENCE OF ANEMIA
The mean Hgb level of pregnant women was 10.98g/dL 
(± 1.68g/dL SD). The minimum and Hgb value of the study 
participant were 4.0 g/dL and 18.5 g/dL, respectively [Figure 1]. 
The overall prevalence of maternal anemia was 508 (45.4%). Out 
of the total anemic pregnant women, 256 (50.4%), 236 (46.5%), 
and 16 (3.1%) of them were mildly, moderately, and severely 
anemic, respectively [Figure 2].
High prevalence of anemia was observed in those pregnant 
women who were within the age of 31-35 years (53.1%) and 
who were rural residents (50.7%) [Table 3].
The prevalence of maternal anemia was assessed by taking 
obstetrical and medical conditions of pregnant women into a 
consideration. High prevalence of anemia was found among 
pregnant women who were being infected with HIV (77.0%), 
who visited ANC four times (50.5%) and who were at second 
trimester during their last ANC visit (48.4%). About 506 (45.3%) 
of pregnant women who took Nutritional supplementation 
during their current pregnancy were anemic. HIV infection was 
found to be statistically significant factor for a high prevalence 
of anemia among pregnant women. Pregnant women who were 
being infected with HIV had almost five times more likelihood 
of being anemic when compared to those pregnant women who 
Table 1: Selected sociodemographic characteristics of pregnant 
women who attended ANC service at Bahirdar Felege-Hiwot 











Table 2: Obstetrical and medical characteristics of pregnant 
mothers at their last ANC service at Bahirdar Felege-Hiwot 
Referral Hospital from September 2012 to August 2013
Variables Frequency Percentage
Gestational age
1st trimester (up to 13 weeks) 11 1
2nd trimester (14 week-26 weeks) 283 25.2




3 gravida 254 22.7








Systolic hypertensive only 8 25.6
Diastolic hypertensive only 17 60.7





Visited once 366 32.7
Visited twice 276 24.6
Visited 3 times 264 23.6
Visited≥4 times 214 19.1
ANC: Antenatal care
Table 3: Prevalence of maternal anemia according to selected 
sociodemographic characteristics of pregnant women who 
attended ANC service at Bahirdar Felege-Hiwot Referral 
Hospital from September 2012 to August 2013
Variable Anemic status (n (%)) Total (%) COR (95%Cl)
Anemic Non-anemic
Age
<20 62 (44.9) 76 (55.1) 138 (12.3) 1
21-25 190 (45.3) 229 (54.7) 419 (37.4) 1.02 (0.69,1.50)
26-30 186 (43.5) 242 (56.5) 428 (38.2) 0.94 (0.64,1.39)
31-35 51 (53.1) 45 (46.9) 96 (8.6) 1.39 (0.82, 2.34)
>35 19 (48.7) 20 (51.3) 39 (3.5) 1.16 (0.57, 2.38)
Residence
Urban 437 (44.6) 543 (55.4) 980 (87.5) 1
Rural 71 (50.70) 69 (49.30) 140 (12.5) 1.28 (0.87,1.76)
ANC: Antenatal care
Figure 1: The hemoglobin value distribution of pregnant women who 
attended antenatal care service at Bahirdar Felege-Hiwot Referral 
hospital from September 2012 to August 2013
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were HIV sero-negative (adjusted odds ratio [95%CI] = 4.78 
[3.14, 7.29]). ANC visit was significantly associated with anemia 
in bivariate analysis. But when adjusted for confounding factors 
in multivariate analysis, it had not significant association. The 
reason might be due the fact that the distribution of anemia 
is comparable across all categories ranging from 44% to 50.5%. 
Moreover, in developing countries like Ethiopia, the habit of 
ANC attendance is low unless they are symptomatically ill 
[Table 4].
DISCUSSION
The overall prevalence of anemia in this study population using 
a cut-off level of Hb <11 g/dl was 45.5% (508/1120). This is 
considerably comparable to studies conducted in Southeastern 
Nigeria (40.4%) [31]. The result of this study is also in agreement 
with 2008 WHO’s report in which 41.8% of pregnant women 
were suffering from anemia [26].
The prevalence of anemia was higher than similar studies 
conducted in Trinidad and Tobago (15.3%) [26], Southwest 
Nigeria (30%) [32], West Arsi zone, Ethiopia (36.6%) [15], 
Southeast Ethiopia (27.9%) [12], Addis Ababa, Ethiopia 
(21.3%) [13], Azezo health center, Ethiopia (21.1%) [10] 
and Gondar town (16.6%) [9]. The possible reasons for this 
disparity might be attributed to the geographical variation of 
factors across different areas like infectious diseases, difference 
in socio-economic status and the time gap between the current 
study and the above studies.
However, the prevalence of anemia in the current study is lower 
than similar studies conducted in Burkina Faso (66%) [33], Rivers 
state, Nigeria (62.6%) [34] and Pakistan (56.1%) [35]. High 
prevalence of anemia in western African countries and Pakistan 
might be due the burden of hemoglobinopathies [36-38]. 
Likewise, the prevalence of anemia in the current study is lower 
than the study conducted in Eastern Ethiopia (56.8%) [30] 
and Gilgel gibe, South Western Ethiopia (53.9%) [14]. The 
difference might be due to the fact that Eastern and South 
Western Ethiopia are malaria epidemic areas which may 
Figure 2: Severity of anemia among anemic pregnant women who 
attended antenatal care service at Bahirdar Felege-Hiwot Referral 
Hospital from September 2012 to August 2013 (n = 508)
Table 4: The prevalence of maternal anemia according to the obstetrics and medical characteristics and nutritional 
supplementation among pregnant women who attended ANC service at Bahirdar Felege-Hiwot Referral Hospital from 
September 2012 to August 2013
Variables Anemic status (%) COR (95%Cl) AOR (95%CI)
Anemic Non-anemic Total
HIV
Sero-positive 104 (77.0) 31 (23.0) 135 (12.0) 4.83 (3.16,7.35)* 4.78 (3.14, 7.29)*
Sero-negative 404 (41.0) 581 (59.0) 985 (87.9) 1
Gestation age
1st trimester 5 (45.5) 6 (54.5) 11 (0.98) 1
2nd trimester 137 (48.4) 146 (51.5) 283 (25.2) 1.04 (0.32,346)
3rd trimester 366 (44.3) 460 (55.7) 826 (73.8) 1.18 (0.90,1.5)
Gravidity
Primigravidae 282 (46.2) 328 (53.8) 610 (54.5) 1
Secundigravidae 81 (42.4) 110 (57.6) 191 (17) 0.87 (0.62, 1.19)
3 gravida 116 (45.7) 138 (54.3) 254 (22.7) 0.98 (0.73, 1.31)
≥4 gravida 29 (44.6) 36 (55.4) 65 (5.8) 0.94 (0.56, 1.57)
Hypertension
Hypertensive 12 (42.9) 16 (57.1) 28 (2.5) 0.90 (0.42,1.92)
Non-hypertensive 496 (45.4) 596 (54.6) 1092 (97.5) 1
ANC follow-up
Visited once 161 (44.0) 205 (56.0) 366 (32.7) 0.77 (0.55,1.08) 0.92 (0.65, 1.31)
Visited twice 130 (47.1) 146 (52.9) 276 (24.6) 0.87 (0.61.1.25) 0.94 (0.65, 1.36)
Visited 3 times 109 (41.3) 155 (58.7) 264 (23.6) 0.69 (0.48,0.99) 0.73 (0.5, 1.10)
Visited>4 times 108 (50.5) 106 (49.5) 214 (19.1) 1
Nutritional supplementation
Yes 506 (45.3) 612 (54.7) 1118 (98.8)
No 2 (100) 0 2 (0.2)
Bold numerical value indicates statistically significant in bivariate but not in multivariate analysis. *significant at P<0.001 in both bivariate and 
multivariate analysis, ANC: Antenatal Care, AOR: Adjusted odds ratio, CI: Confidence interval
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contribute for the increasing magnitude of anemia among 
pregnant women.
In our study, residence and age were not significantly associated 
with maternal anemia. This is in agreement with studies done 
in Rivers state Nigeria [34], Gondar, Ethiopia [9], Eastern 
Ethiopia [30] and Southeast Ethiopia [12]. However, it is 
in contrast to the studies conducted at Azezo health center, 
Ethiopia [10] and Gilgel gibe, Ethiopia [14] in which residential 
area of the pregnant women and age were statistically associated 
with maternal anemia. The possible reasons for the difference 
may be explained that in our study majority of pregnant women 
were from urban setting area whereas in Azezo and Gilgel 
gibe studies urban and rural residence proportion of the study 
participants was not much exaggerated.
In our study, the predominant type of anemia was mild type 
(50.4%) followed by moderate type (46.5%). This finding is in line 
with studies conducted in South Eastern Nigeria [31], Southeast 
Ethiopia [12], Addis Ababa, Ethiopia [13], Gilgel gibe [14], 
Gondar town, Ethiopia [9] and Azezo health center [10]. 
However, it contradicts with studies conducted in Burkina 
Faso [33] and teaching hospital in Southwestern Nigeria [39] in 
which moderate type was predominant followed by mild type. 
This variation might be attributed to the difference in socio-
demographic and lifestyle between study participants. It might 
also be the result of differences in policies and strategies placed to 
reduce maternal mortality and morbidity across these countries.
In the current study, pregnant women who had been HIV sero-
positive were five times more likely to be anemic compared 
with HIV sero-negative pregnant women. This is consistent 
with studies conducted in Southeastern Nigeria, Southwester 
Nigeria, Burkina Faso, Gondar town, Ethiopia [9,31-33]. The 
possible reason might be due to the deregulation of host 
immune system leading to destruction and/or inhibition of 
hematopoietic cells and under-regulated utilization of serum 
micronutrients during HIV infection [9].
In the current study, the prevalence of anemia among pregnant 
women was high. According to WHO classification of the 
public health importance of anemia [3], it is a severe public 
health problem. The predominant type of anemia was mild type 
followed by moderate anemia. HIV infection was significantly 
associated with maternal anemia. There is a need to design 
strategies and program that promote mothers to be screened 
for HIV before getting pregnancy. Pregnant women should also 
be encouraged to have early and regular ANC follow-up for 
early diagnosis and management of HIV infection and other 
health-related problems. Furthermore, since the current study 
was institutional-based retrospective study, further in-depth 
community-based studies should have to be conducted to 
investigate determinants of maternal anemia during pregnancy.
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